Showing results (31-40 of 58) with videos related to
Sort By:
Pageof 6
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 5, 2024
Mobility trajectories in multiple sclerosis: A comparative study of timed 25-foot walk and a patient-reported outcome measureFarren Bs Briggs, Douglas D Gunzler, Deborah M Miller, et al.Journal of Sleep Research|November 23, 2006
Temazepam at high altitude reduces periodic breathing without impairing next-day performance: a randomized cross-over double-blind studyAnnabel H Nickol, Juliette Leverment, Paul Richards, et al.Complementary Therapies in Medicine|August 8, 2022
Components of a successful community-based exercise program for individuals with Parkinson's disease: Results from a participant surveyAnson B Rosenfeldt, Mandy Miller Koop, Amanda L Penko, et al.Neurodegenerative Disease Management|April 16, 2024
Comparison of time to clinically meaningful improvement in quality of life in neurological disorders in patients treated with natalizumab versus ocrelizumabCarrie M Hersh, Menglan Pang, Deborah M Miller, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|March 23, 2026
Relationships between neighborhood deprivation, race, and worsening outcomes among MS patients 55 years of age and olderDeborah M Miller, Yadi Li, Scott Husak, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|October 18, 2024
Multiple sclerosis subgroups: Data-driven clusters based on patient-reported outcomes and a large clinical sampleAlessandro S De Nadai, Ryan J Zamora, Alyse Finch, et al.Journal of Patient Experience|October 16, 2020
Obtaining Patient Priorities in a Multiple Sclerosis Comprehensive Care Center: Beyond Patient-Reported OutcomesDeborah M Miller, Brandon Moss, Susannah Rose, et al.Medical Decision Making : an International Journal of the Society for Medical Decision Making|October 5, 2020
A Scoring Algorithm for Deriving Utility Values from the Neuro-QoL for Patients with Multiple SclerosisLouis S Matza, Glenn Phillips, Barry Dewitt, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|August 13, 2014
Factors associated with clinically significant increased walking time in multiple sclerosis: results of a survival analysis of short-term follow-up data from a clinical databaseDeborah M Miller, Nicolas R Thompson, Jeffrey A Cohen, et al.Journal of the Neurological Sciences|May 22, 2016
Impact of a switch to fingolimod on depressive symptoms in patients with relapsing multiple sclerosis: An analysis from the EPOC (Evaluate Patient OutComes) trialSamuel F Hunter, Mark Agius, Deborah M Miller, et al.Pageof 6